MediClin AG (XTER:MED) Cyclically Adjusted FCF per Share: €0.68 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:MED MediClin AG XTER:MED
78 GF Score
Price €4.16
GF Value €3.04
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is MediClin AG Cyclically Adjusted FCF per Share?

MediClin AG XTER:MED 78 Cyclically Adjusted FCF per Share is €0.68 as of Mar. 2026. GuruFocus rates XTER:MED with a GF Score™ of 78/100 and a GF Value™ of €3.04 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

MediClin AG's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.070. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.68 for the trailing ten years ended in Mar. 2026.

During the past 12 months, MediClin AG's average Cyclically Adjusted FCF Growth Rate was 19.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 31.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of MediClin AG was 51.80% per year. The lowest was 20.70% per year. And the median was 21.10% per year.

As of today (2026-07-19), MediClin AG's current stock price is €4.16. MediClin AG's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.68. MediClin AG's Cyclically Adjusted Price-to-FCF of today is 6.12.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MediClin AG was 80.40. The lowest was 4.40. And the median was 6.98.


MediClin AG  (XTER:MED) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

MediClin AG's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=4.16/0.68
=6.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MediClin AG was 80.40. The lowest was 4.40. And the median was 6.98.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


MediClin AG Cyclically Adjusted FCF per Share Related Terms


MediClin AG Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for MediClin AG's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediClin AG Cyclically Adjusted FCF per Share Chart

MediClin AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.31 0.37 0.49 0.55 0.65

MediClin AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.60 0.63 0.65 0.68

XTER:MED vs HCA, THC, DVA: Cyclically Adjusted FCF per Share Comparison

For the Medical Care Facilities subindustry, MediClin AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG Cyclically Adjusted Price-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MediClin AG's Cyclically Adjusted Price-to-FCF falls into.


XTER:MED
78GF Score
MediClin AG XTER:MED
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediClin AG Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MediClin AG's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.07/131.2583*131.2583
=0.070

Current CPI (Mar. 2026) = 131.2583.

MediClin AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.111 100.717 -0.145
201609 0.243 101.017 0.316
201612 -0.009 101.217 -0.012
201703 -0.260 101.417 -0.337
201706 -0.148 102.117 -0.190
201709 0.067 102.717 0.086
201712 -0.027 102.617 -0.035
201803 -0.067 102.917 -0.085
201806 -0.201 104.017 -0.254
201809 0.081 104.718 0.102
201812 -0.194 104.217 -0.244
201903 0.009 104.217 0.011
201906 0.111 105.718 0.138
201909 0.233 106.018 0.288
201912 0.073 105.818 0.091
202003 0.094 105.718 0.117
202006 0.881 106.618 1.085
202009 0.537 105.818 0.666
202012 0.407 105.518 0.506
202103 0.202 107.518 0.247
202106 0.165 108.486 0.200
202109 0.574 109.435 0.688
202112 0.402 110.384 0.478
202203 0.205 113.968 0.236
202206 -0.217 115.760 -0.246
202209 0.333 118.818 0.368
202212 -0.188 119.345 -0.207
202303 0.211 122.402 0.226
202306 -0.079 123.140 -0.084
202309 0.389 124.195 0.411
202312 0.330 123.773 0.350
202403 0.171 125.038 0.180
202406 -0.071 125.882 -0.074
202409 0.524 126.198 0.545
202412 0.143 127.041 0.148
202503 0.136 127.779 0.140
202506 0.111 128.412 0.113
202509 0.623 129.255 0.633
202512 0.231 129.361 0.234
202603 0.070 131.258 0.070

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.68 mean?
MediClin AG (XTER:MED) has a Cyclically Adjusted FCF per Share of €0.68 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MediClin AG and its competitors.
Is MediClin AG's Cyclically Adjusted FCF per Share too high?
MediClin AG's current Cyclically Adjusted FCF per Share is €0.68. Overall, MediClin AG has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's Cyclically Adjusted FCF per Share compare to HCA and THC?
MediClin AG's Cyclically Adjusted FCF per Share of €0.68 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted FCF per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MediClin AG and its competitors. MediClin AG's current Cyclically Adjusted FCF per Share is €0.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (XTER:MED) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.04, compared to a current price of €4.16 — trading 36.8% above its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.68. MediClin AG's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For MediClin AG (XTER:MED), the current Cyclically Adjusted FCF per Share is €0.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MediClin AG (XTER:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €4.16 is trading 36.8% above its estimated GF Value™ of €3.04. GuruFocus considers MediClin AG to be Significantly Overvalued.

Key valuation signals for XTER:MED:

  • Cyclically Adjusted FCF per Share: €0.68
  • GF Value™: €3.04 vs. price of €4.16 (36.8% above fair value)
  • GF Score™: 78/100 with 6 warning signs

No single metric tells the full story. See the XTER:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediClin AG Business Description

Other Exchanges 0NDG:UK
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
78GF Score

Get the complete analysis for XTER:MED

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.16
Price
€3.04
GF Value